Utility of <I>SF3B1</I> mutation screening at diagnosis for myelodysplastic syndrome with ring sideroblasts

Shumpei Mizuta

Presentation information

Poster Session

Fri. Oct, 12

Poster Session 1-5 MDS: Basic

Fri. Oct 12, 2018 5:30 PM - 6:10 PM Poster1 (Osaka International Convention Center, 3F Event Hall)

Chair: Hiromichi Matsushita (National Cancer Center Hospital Division of Pathology and Clinical Laboratories)

[PS1-5-3] Utility of SF3B1 mutation screening at diagnosis for myelodysplastic syndrome with ring sideroblasts

Shumpei Mizuta¹, Noriko Yamane¹, Takao Komai¹, Yusuke Koba², Takahito Kawata², Naoya Ukyo², Akira Tamekane², Mitsumasa Watanabe² (1.Department of Clinical Laboratory, Hyogo Prefectural AGMC, Hyogo, Japan, 2.Department of Hematology, Hyogo Prefectural AGMC, Hyogo, Japan)

Abstract password authentication.
Password is written on a program and abstract book.